You are here Journals » ClinicoEconomics and Outcomes Research » Volume 3

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Total article views   HTML views PDF downloads Totals
18,137 Dovepress* 16,594 3,563 20,157
PubMed Central* 1,543 780 2,323
Totals 18,137 4,343 22,480
*Since 25 January 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed and Google Scholar